Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
-
Tango Therapeutics raises $225 million in stock offering
-
Minerva Neurosciences secures up to $200 million for schizophrenia drug trial
-
GRAIL raises $325 million in private placement financing
-
Form SCHEDULE 13G Crinetics Pharmaceutical Filed by: Farallon Capital Partners, L.P.
-
Form N-PX FARALLON CAPITAL MANAGEM For: Jun 30
-
GoPro registers warrant resale covering 11 million shares
-
Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
-
Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Marblegate Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SCHEDULE 13G/A NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
-
Assembly Biosciences prices $175 million equity financing with Gilead
-
GoPro secures $50 million term loan from Farallon Capital
-
Visteon appoints Marjorie Sennett to board of directors
-
Form SCHEDULE 13G Liquidia Corp Filed by: Farallon Capital Partners, L.P.
-
Form D/A Farallon Capital F5 Inve
-
Form D/A Farallon Capital F5 Inve
-
Form SCHEDULE 13G 23andMe Holding Co. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
-
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form D/A FARALLON CAPITAL OFFSHOR
-
Form D/A Farallon Capital Partner
-
Form D/A Farallon Capital (AM)
-
Form D/A Farallon Capital Institu
-
Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.

